• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 413024 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416863414 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416863414 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Immunogen Makes a Move: Up 2.6%

Published on Mon, 12/31/2012 - 13:25
By Peter Chu

Immunogen (NASDAQ:IMGN) is one of today's biggest movers, up 2.6% to $12.73. The S&P is currently trading 0.9% higher to 1,416 and the Dow Jones Industrial Average is trading 0.7% higher to 13,025.

ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The Company's tumor activated prodructs deliver chemotherapy specifically to a tumor. ImmunoGen has three drugs in clinical trials and is negotiating to take a drug into phase II trial. These products are being tested for the treatment of colorectal and small-cell lung cancer.

Over the past year, Immunogen has traded in a range of $9.17 to $18.10 and is now at $12.73, 39% above that low. The 200-day and 50-day moving averages have moved 0.09% lower and 1.35% lower over the past week, respectively.

Immunogen (NASDAQ:IMGN) has potential upside of 3.9% based on a current price of $12.73 and analysts' consensus price target of $13.22. Immunogen shares should encounter resistance at the 200-day moving average (MA) of $13.95 and support at the 50-day MA of $12.40.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Shares of Weyerhaeuser Rise Above Previo...

Shares of Weyerhaeuser (NYSE:WY) traded at a new 52-week high today of $34.76. Approxi ...

Watch for Continued Gains in Shares of V...

Shares of VCA Antech (NASDAQ:WOOF) traded today at $47.00, breaking its 52-week high. ...

Recent 52-Week High Exceeded in Shares o...

Wells Fargo (NYSE:WFC) traded today at a new 52-week high of $54.36. Approximately 6.7 ...

Watch for Continued Gains in Shares of W...

Wabtec (NYSE:WAB) traded at a new 52-week high today of $91.14. So far today approxima ...

Ventas: 52-Week High Recently Eclipsed (...

Shares of Ventas (NYSE:VTR) traded today at $69.92, breaking its 52-week high. This ne ...

Recent 52-Week High Exceeded in Shares o...

Validus Holdings (NYSE:VR) traded today at a new 52-week high of $41.40. This new high ...

US Bancorp Looks to Continue to Trade Ab...

US Bancorp (NYSE:USB) traded today at a new 52-week high of $44.49. Approximately 3.2 ...

Union Pacific Looks to Continue to Trade...

Shares of Union Pacific (NYSE:UNP) traded at a new 52-week high today of $123.37. Appr ...